Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)piperazine
2. Aphilan
3. Bucladin-s
4. Buclizine
5. Buclizine Hydrochloride
6. Softran
1. 129-74-8
2. Buclizine Hydrochloride
3. Longifene
4. Buclizine Hcl
5. Buclina
6. Softran
7. 1-(4-(tert-butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine Dihydrochloride
8. Buclizine, Dihydrochloride
9. Bucladin-s
10. Aphilan
11. Buclodin
12. Ucb 4445
13. Aphilan R
14. Bucladin
15. Buclizine Hydrochloride [usan]
16. Vibazine Hydrochloride
17. Ucb-4445
18. Vibazine
19. Histabutyzine Hydrochloride
20. Histabutyzine Dihydrochloride
21. Buclizine (dihydrochloride)
22. Eop5593fph
23. V4oce982yu
24. 58fqd093nu
25. Buclizine Hydrochloride, (+)-
26. Buclizine Hydrochloride, (-)-
27. Chebi:61193
28. 1-(p-chlorobenzhydryl)-4-(p-t-butylbenzyl)diethylenediamine Dihydrochloride
29. 1-(p-tert-butylbenzyl)-4-(p-chloro-alpha-phenylbenzyl)piperazine Dihydrochloride
30. 1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenylmethyl]piperazine;dihydrochloride
31. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, Dihydrochloride
32. Postafeno
33. A 7668
34. Bucladin S
35. Nsc-25141
36. 1-(4-(tert-butyl)benzyl)-4-((4-chlorophenyl)-(phenyl)methyl)piperazine Dihydrochloride
37. Buclizine Hydrochloride (usan)
38. 1-(p-tert-butylbenzyl)-4-(p-chlorodiphenylmethyl)piperazine Dihydrochloride
39. Buclizine 2hcl
40. 163837-35-2
41. 163837-36-3
42. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, Dihydrochloride, (+)-
43. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, Dihydrochloride, (-)-
44. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, Hydrochloride (1:2)
45. Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[[4-(1,1-dimethylethyl)phenyl]methyl]-, Dihydrochloride
46. Einecs 204-962-4
47. Nsc 25141
48. Unii-58fqd093nu
49. Vibazine (tn)
50. 1-(p-tert-butylbenzyl)-4-(p-chloro-.alpha.-phenylbenzyl)piperazine Dihydrochloride
51. 1-p-chlorobenzhydryl-4-p-(t)-butylbenzylpiperazine Dihydrochloride
52. Unii-eop5593fph
53. Unii-v4oce982yu
54. Dsstox_cid_25091
55. Dsstox_rid_80665
56. Dsstox_gsid_45091
57. Schembl123751
58. Chembl2360580
59. Dtxsid5045091
60. Perlapine, >=98% (hplc)
61. Hy-a0128a
62. Bcp22428
63. Tox21_110023
64. Mfcd00242700
65. S4140
66. Buclizine Dihydrochloride [mi]
67. 5-isopropyl-2-methoxyphenylboronicacid
68. Akos016004771
69. Bcp9000459
70. Buclizine Hydrochloride [mart.]
71. Buclizine Hydrochloride [vandf]
72. Ks-1250
73. Buclizine Hydrochloride [who-dd]
74. Piperazine, 1-(p-tert-butylbenzyl)-4-(p-chloro-alpha-phenylbenzyl)-, Dihydrochloride
75. Ncgc00013315-01
76. Ac-32891
77. Cas-129-74-8
78. Bcp0726000050
79. Buclizine Dihydrochloride, >=98% (hplc)
80. Buclizine Hydrochloride [orange Book]
81. Cs-0019690
82. Ft-0663892
83. D02089
84. 129b748
85. J-005711
86. Q27130875
87. (rs)-1-(4-t-butylbenzyl)-4-(4-chlorobenzhydryl) Piperazine Dihydrochloride
88. 1-(4-(tert-butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazinedihydrochloride
89. 1-(4-tert-butylbenzyl)-4-[(4-chlorophenyl)(phenyl)methyl]piperazine Dihydrochloride
90. 1-(4-tert-butylbenzyl)-4-[(4-chlorophenyl)(phenyl)methyl]piperazinediium Dichloride
91. 7139-55-1
Molecular Weight | 505.9 g/mol |
---|---|
Molecular Formula | C28H35Cl3N2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 6 |
Exact Mass | 504.186582 g/mol |
Monoisotopic Mass | 504.186582 g/mol |
Topological Polar Surface Area | 6.5 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 514 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Histamine Antagonists
Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?